The Pros, Cons, and Unknowns of Search and Destroy for Carbapenem-Resistant Enterobacteriaceae

Current Infectious Disease Reports

Volumn 17, Issue 6, 2015, Pages

  Moodley, Prashini ^a   Whitelaw, Andrew ^b,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Antibiotic drug discovery; Carbapenem resistant Enterobacteriaceae

Indexed keywords

ANTIBIOTIC AGENT;

CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; COST EFFECTIVENESS ANALYSIS; DISEASE CARRIER; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MEDICAL PRACTICE; PATIENT CARE; REVIEW; SCREENING; SEARCH AND DESTROY; WASTE MANAGEMENT;

EID: 84928803008     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-015-0483-8     Document Type: Review

References (86)

1. Chambers HF, Deleo FR. Waves of resistance: staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629–41.
2. Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents. 2000;16 Suppl 1:S3–10.
3. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28–106.
4. Kock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill: Bull Eur sur les Maladies Transmissibles = Eur Communicable Dis Bull. 2010;15(41):19688.
5. Boyce JM, Suppl A. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect. 2001;48:S9–14.
6. Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA technical panel on infections within hospitals. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 1994;15(2):105–15.
7. Ribeiro J, Boyce JM, Zancanaro PQ. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients visiting the emergency room at a tertiary hospital in Brazil. Braz J Infect Dis: Off Publ Braz Soc Infect Dis. 2005;9(1):52–5.
8. Abecasis F, Kerr S, Sarginson RE, Silvestri L, de la Cal MA, Zandstra D, et al. Comment on: emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother. 2007;60(2):445. author reply 446.
9. Petros A, Roos D, van Saene H, Taylor N, Rommes H, Silvestri L. Selective decontamination of the digestive tract may reduce perioperative risk in elective surgery. BMJ. 2011;343:d7536. author reply 7542.
10. Petros AJ, Silvestri L, Taylor N, Abecasis F, Damjanovic V, de la Cal MA, et al. Comment on: Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands. J Antimicrob Chemother. 2014;69(3):860.
11. Silvestri L, de la Cal MA, Taylor N, van Saene HK, Parodi PC. Selective decontamination of the digestive tract in burn patients: an evidence-based maneuver that reduces mortality. J Burn Care Res: Off Publ Am Burn Assoc. 2010;31(2):372–3. author reply 374.
12. Silvestri L, Mannucci F, van Saene HK. Selective decontamination of the digestive tract: a life saver. J Hosp Infect. 2000;45(3):185–90.
13. Silvestri L, Petros AJ, Viviani M, Rommes JH, van Saene HK. Selective decontamination of the digestive tract and ventilator-associated pneumonia (part 1). Respir Care. 2006;51(1):67–9. author reply 70–62.
14. Silvestri L, van Saene HK. Selective decontamination of the digestive tract does not increase resistance in critically ill patients: evidence from randomized controlled trials. Crit Care Med. 2006;34(7):2027–9. author reply 2029–2030.
15. Silvestri L, van Saene HK, de la Cal MA, Sarginson RE, Thomann C. Prevention of ventilator-associated pneumonia by selective decontamination of the digestive tract. Eur Respir J. 2008;32(1):241–3.
16. Silvestri L, van Saene HK, Milanese M, Gregori D, Gullo A. Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect. 2007;65(3):187–203.
17. Silvestri L, van Saene HK, Petros AJ. Selective digestive tract decontamination in critically ill patients. Expert Opin Pharmacother. 2012;13(8):1113–29.
18. van Saene HK, Damjanovic V, Silvestri L, de la Cal MA, Zandstra DF. Selective decontamination of the digestive tract and ventilator-associated pneumonia (part 2). Respir Care. 2006;51(1):72–5. author reply 75.
19. Petros A, Silvestri L, Booth R, Taylor N, van Saene H. Selective decontamination of the digestive tract in critically ill children: systematic review and meta-analysis. Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2013;14(1):89–97.
20. Zandstra DF, Petros AJ, Silvestri L, de la Cal MA, Taylor N, Damjanovic V, et al. Selective decontamination of the digestive tract: selectivity is not required. Intensive Care Med. 2010;36(10):1783–4.
21. Zandstra DF, Petros AJ, Taylor N, Silvestri L, de la Cal MA, van Saene HK. Withholding selective decontamination of the digestive tract from critically ill patients must now surely be ethically questionable given the vast evidence base. Crit Care. 2010;14(5):443.
22. Petros AJ, Silvestri L, van Saene HK, Zandstra DF, de la Cal MA, Viviani M, et al. 2B or not 2B for selective decontamination of the digestive tract in the surviving sepsis campaign guidelines. Crit Care Med. 2013;41(11):e385–6.
23. Kollef MH, Micek ST. Rational use of antibiotics in the ICU: balancing stewardship and clinical outcomes. JAMA. 2014;312(14):1403–4.
24. Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti-Infect Ther. 2014;12(5):565–80.
25. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2011;53(1):60–7.
26. Williams RJ. Epidemiology of antibiotic resistance in gram-negative bacteria. J Hosp Infect. 1988;11(Suppl A):130–4.
27. Williams RJ, Heymann DL. Containment of antibiotic resistance. Science. 1998;279(5354):1153–4.
28. Williams RJ, Lindridge MA, Said AA, Livermore DM, Williams JD. National survey of antibiotic resistance in Pseudomonas aeruginosa. J Antimicrob Chemother. 1984;14(1):9–16.
29. Yang YJ, Livermore DM, Williams RJ. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae. J Med Microbiol. 1988;25(3):227–33.
30. Kim NH, Han WD, Song KH, Seo HK, Shin MJ, Kim TS, et al. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance. Am J Infect Control. 2014;42(12):1270–3.
31. Barbarini D, Russello G, Brovarone F, Capatti C, Colla R, Perilli M, et al. Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: report from the trench. Infect Gen Evol: J Mol Epidemiol Evol Gen Infect Dis. 2014;30C:8–14.
32. Muscarella LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc. 2014;6(10):457–74.
33. Zurawski RM. Carbapenem-resistant enterobacteriaceae: occult threat in the intensive care unit. Crit Care Nurse. 2014;34(5):44–52.
34. Rafailidis PI, Falagas ME. Options for treating carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2014;27(6):479–83.
35. Temkin E, Adler A, Lerner A, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann N Y Acad Sci. 2014;1323:22–42.
36. Hsieh WS, Wang NY, Feng JA, Weng LC, Wu HH. Molecular surveillance and prevalence of carbapenem-resistant Enterobacteriaceae in northern Taiwan. J Antimicrob Chemother. 2014;69(10):2871–3.
37. Yamamoto M, Pop-Vicas AE. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Crit Care. 2014;18(3):229.
38. Thaden JT, Lewis SS, Hazen KC, Huslage K, Fowler Jr VG, Moehring RW, et al. Rising rates of carbapenem-resistant Enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(8):978–83.
39. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170–5.
40. Palmore TN, Henderson DK. Carbapenem-resistant Enterobacteriaceae: a call for cultural change. Ann Intern Med. 2014;160(8):567–9.
41. Dirajlal-Fargo S, DeBiasi R, Campos J, Song X. Carbapenem-resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):447–9.
42. Drekonja DM, Beekmann SE, Elliott S, Mukundan D, Polenakovik H, Rosenthal ME, et al. Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):437–9.
43. Pisney LM, Barron MA, Kassner E, Havens D, Madinger NE. Carbapenem-resistant Enterobacteriaceae rectal screening during an outbreak of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae at an acute care hospital. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):434–6.
44. Fitzpatrick M, Zembower T, Malczynski M, Qi C, Bolon MK. Outcomes of an enhanced surveillance program for carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):419–22.
45. Landry J, Hurst H. The emerging threat from carbapenem-resistant enterobacteriaceae. NursWomens Health. 2013;17(6):519–24.
46. Johnson K, Boucher HW. Editorial commentary: imminent challenges: carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancy. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2014;58(9):1284–6.
47. Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2014;58(5):697–703. This study demonstrates the results that can be obtained through a nationally co-ordinated response to the challenge of CRE.
48. Kruse EB, Aurbach U, Wisplinghoff H. Carbapenem-resistant Enterobacteriaceae: laboratory detection and infection control practices. Curr Infect Dis Rep. 2013.
49. Palmore TN, Henderson DK. Managing transmission of carbapenem-resistant Enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2013;57(11):1593–9.
50. Arend LN, Pilonetto M, de Alencar Siebra C, Tuon FF. Phenotypic and molecular characterization of 942 carbapenem-resistant Enterobacteriaceae (CRE) in southern Brazil. J Infect Chemother: Off J Jpn Soc Chemother. 2014.
51. Banach DB, Francois J, Blash S, Patel G, Jenkins SG, LaBombardi V, et al. Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(1):82–4.
52. Betts JW, Phee LM, Hornsey M, Woodford N, Wareham DW. In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2014;58(6):3541–6.
53. Birgy A, Bidet P, Genel N, Doit C, Decre D, Arlet G, et al. Phenotypic screening of carbapenemases and associated beta-lactamases in carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2012;50(4):1295–302.
54. Boyce JM, Havill NL. Comparison of BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR versus the CHROMagar MRSA assay for screening patients for the presence of MRSA strains. J Clin Microbiol. 2008;46(1):350–1.
55. Havill NL, Boyce JM. Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in stool specimens. J Clin Microbiol. 2010;48(6):2228–30.
56. Kazi M, Drego L, Nikam C, Ajbani K, Soman R, Shetty A, Rodrigues C. Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai. Eur J Clin Microbiol Infect Dis: Off Publ Eur Soc Clin Microbiol. 2014.
57. Kim J, Lee JY, Kim SI, Song W, Kim JS, Jung S, et al. Rates of fecal transmission of extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med. 2014;34(1):20–5.
58. Lerner A, Romano J, Chmelnitsky I, Navon-Venezia S, Edgar R, Carmeli Y. Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2013;57(3):1474–9.
59. Michalska AD, Sacha PT, Ojdana D, Majewski P, Wieczorek P, Tryniszewska E. Carbapenem-resistant strains from the family Enterobacteriaceae isolated in the period 2006–2011 from clinical specimens of patients treated at the university hospital in northeastern Poland. Medycyna Doswiadczalna i Mikrobiologia. 2013;65(1):27–38.
60. Pereira EC, Shaw KM, Vagnone PM, Harper JE, Kallen AJ, Limbago BM, et al. Thirty-day laboratory-based surveillance for carbapenem-resistant Enterobacteriaceae in the Minneapolis-St. Paul Metropolitan Area Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):423–5.
61. Pollett S, Miller S, Hindler J, Uslan D, Carvalho M, Humphries RM. Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013. J Clin Microbiol. 2014;52(11):4003–9.
62. Samra Z, Bahar J, Madar-Shapiro L, Aziz N, Israel S, Bishara J. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2008;46(9):3110–1.
63. Schechner V, Kotlovsky T, Tarabeia J, Kazma M, Schwartz D, Navon-Venezia S, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol: Official J Soc Hosp Epidemiol Am. 2011;32(5):497–503.
64. Villar HE, Baserni MN, Jugo MB. Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings. J Infect Dev Ctries. 2013;7(8):630–4.
65. Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol. 2011;49(6):2239–42.
66. Gazin M, Paasch F, Goossens H, Malhotra-Kumar S, Mosar WP, Teams SWS. Current trends in culture-based and molecular detection of extended-spectrum-beta-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2012;50(4):1140–6.
67. Lau AF, Wang H, Weingarten RA, Drake SK, Suffredini AF, Garfield MK, et al. A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2014;52(8):2804–12.
68. Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012;50(12):3877–80.
69. Poulou A, Voulgari E, Vrioni G, Xidopoulos G, Pliagkos A, Chatzipantazi V, et al. Imported Klebsiella pneumoniae carbapenemase-producing K. pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination. J Clin Microbiol. 2012;50(8):2618–23. This study described the impact that can be made by a “package” of IPC practices, and re-emphasises the need for a multi-faceted approach.
70. Kochar S ST, Sharma R, et al. Vital Signs: Carbapenem-resistant Enterobacteriaceae. In: Morbidity and mortality weekly report (MMWR). vol. 09. Atlanta: Centers for Disease Control and Prevention; 2013: 165–170.
71. Landman D, Babu E, Shah N, Kelly P, Olawole O, Backer M, et al. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother. 2012;67(6):1427–31.
72. Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41(3):190–4.
73. Feldman N, Adler A, Molshatzki N, Navon-Venezia S, Khabra E, Cohen D, et al. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2013;19(4):E190–6.
74. Savard P, Perl TM. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(9):854–61.
75. Drees M, Pineles L, Harris AD, Morgan DJ. Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):362–6.
76. Saidel-Odes L, Polachek H, Peled N, Riesenberg K, Schlaeffer F, Trabelsi Y, et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2012;33(1):14–9.
77. Vandenbroucke-Grauls CM, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet. 1991;338(8771):859–62.
78. Liberati A, D’Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev. 2009;4:CD000022.
79. Silvestri L, van Saene HK, de la Cal MA, Zandstra DF, Viviani M, Peric M, et al. Surviving sepsis campaign needed consensus to exclude selective decontamination of the digestive tract. Crit Care Med. 2008;36(9):2716–7.
80. Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2011;52(7):848–55.
81. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2010;16(2):102–11.
82. Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infect Control. 2013;41(12):1167–72.
83. Lubbert C, Faucheux S, Becker-Rux D, Laudi S, Durrbeck A, Busch T, et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents. 2013;42(6):565–70.
84. Kontopidou F, Giamarellou H, Katerelos P, Maragos A, Kioumis I, Trikka-Graphakos E, et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(2):O117–23.
85. Mathers AJ, Poulter M, Dirks D, Carroll J, Sifri CD, Hazen KC. Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):350–5.
86. O’Neil J. Review on antimicrobial resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. In: Edited by resistance RoA, 01 edn. London, UK; 2014.